Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Monday, March 9, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Medtech
Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding
Life Sciences Times
-
March 4, 2026
0
Technology
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
Life Sciences Times
-
March 3, 2026
0
Biotech
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
Life Sciences Times
-
March 3, 2026
0
Venture Capital
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
Life Sciences Times
-
March 3, 2026
0
Pharma
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
Life Sciences Times
-
March 3, 2026
0
People on the Move
Konovo Appoints Jessica Santos as Chief Compliance and Privacy Officer
Life Sciences Times
-
March 3, 2026
0
Public Health
Surescripts Reports Record Growth in Interoperability and Faster Prescription Access in 2025
Life Sciences Times
-
March 3, 2026
0
Healthcare
Dental Tech Firm LightSpun Partners with Smile America to Speed Up Care for 500,000 Underserved Children
Life Sciences Times
-
March 3, 2026
0
Pharma
KalVista Highlights Patient Satisfaction, Early Treatment Benefits for EKTERLY at Major Allergy Meetings
Life Sciences Times
-
March 2, 2026
0
Medtech
Lucent Diagnostics, Life Line Screening Partner to Expand Community Access to Blood-Based Testing
Life Sciences Times
-
March 2, 2026
0
1
2
3
4
...
807
Page 3 of 807
Most Popular
Newton Women’s Health Company Reports Study Showing Leva Device Improves Fecal Incontinence Symptoms
March 9, 2026
Study Suggests Daily Multivitamin May Slow Biological Aging
March 9, 2026
FDA Grants Priority Review to ENHERTU for High-Risk HER2-Positive Early Breast Cancer
March 9, 2026
UK Biotech Firm Abselion Opens U.S. Subsidiary in Cambridge Innovation Hub
March 9, 2026
Load more
Recent Comments
Recent Comments